Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Aging- and obesity-related peri-muscular adipose tissue accelerates muscle atrophy.

Zhu S, Tian Z, Torigoe D, Zhao J, Xie P, Sugizaki T, Sato M, Horiguchi H, Terada K, Kadomatsu T, Miyata K, Oike Y.

PLoS One. 2019 Aug 23;14(8):e0221366. doi: 10.1371/journal.pone.0221366. eCollection 2019.

2.

Protective effect of polaprezinc on cadmium-induced injury of lung epithelium.

Kimura K, Nakano Y, Sugizaki T, Shimoda M, Kobayashi N, Kawahara M, Tanaka KI.

Metallomics. 2019 Jul 17;11(7):1310-1320. doi: 10.1039/c9mt00060g.

PMID:
31236550
3.

Loss of Endogenous HMGB2 Promotes Cardiac Dysfunction and Pressure Overload-Induced Heart Failure in Mice.

Sato M, Miyata K, Tian Z, Kadomatsu T, Ujihara Y, Morinaga J, Horiguchi H, Endo M, Zhao J, Zhu S, Sugizaki T, Igata K, Muramatsu M, Minami T, Ito T, Bianchi ME, Mohri S, Araki K, Node K, Oike Y.

Circ J. 2019 Jan 25;83(2):368-378. doi: 10.1253/circj.CJ-18-0925. Epub 2018 Nov 27.

4.

Association of circulating ANGPTL 3, 4, and 8 levels with medical status in a population undergoing routine medical checkups: A cross-sectional study.

Morinaga J, Zhao J, Endo M, Kadomatsu T, Miyata K, Sugizaki T, Okadome Y, Tian Z, Horiguchi H, Miyashita K, Maruyama N, Mukoyama M, Oike Y.

PLoS One. 2018 Mar 14;13(3):e0193731. doi: 10.1371/journal.pone.0193731. eCollection 2018.

5.

Age-dependent increase in angiopoietin-like protein 2 accelerates skeletal muscle loss in mice.

Zhao J, Tian Z, Kadomatsu T, Xie P, Miyata K, Sugizaki T, Endo M, Zhu S, Fan H, Horiguchi H, Morinaga J, Terada K, Yoshizawa T, Yamagata K, Oike Y.

J Biol Chem. 2018 Feb 2;293(5):1596-1609. doi: 10.1074/jbc.M117.814996. Epub 2017 Nov 30.

6.

Angiopoietin-like protein 2 promotes chondrogenic differentiation during bone growth as a cartilage matrix factor.

Tanoue H, Morinaga J, Yoshizawa T, Yugami M, Itoh H, Nakamura T, Uehara Y, Masuda T, Odagiri H, Sugizaki T, Kadomatsu T, Miyata K, Endo M, Terada K, Ochi H, Takeda S, Yamagata K, Fukuda T, Mizuta H, Oike Y.

Osteoarthritis Cartilage. 2018 Jan;26(1):108-117. doi: 10.1016/j.joca.2017.10.011. Epub 2017 Oct 23.

7.

Treatment of diabetic mice with the SGLT2 inhibitor TA-1887 antagonizes diabetic cachexia and decreases mortality.

Sugizaki T, Zhu S, Guo G, Matsumoto A, Zhao J, Endo M, Horiguchi H, Morinaga J, Tian Z, Kadomatsu T, Miyata K, Itoh H, Oike Y.

NPJ Aging Mech Dis. 2017 Sep 8;3:12. doi: 10.1038/s41514-017-0012-0. eCollection 2017.

8.

Circulating ANGPTL2 Levels Increase in Humans and Mice Exhibiting Cardiac Dysfunction.

Tian Z, Miyata K, Morinaga J, Horiguchi H, Kadomatsu T, Endo M, Zhao J, Zhu S, Sugizaki T, Sato M, Terada K, Okumura T, Murohara T, Oike Y.

Circ J. 2018 Jan 25;82(2):437-447. doi: 10.1253/circj.CJ-17-0327. Epub 2017 Sep 8.

9.

Protective and therapeutic effect of felodipine against bleomycin-induced pulmonary fibrosis in mice.

Tanaka KI, Niino T, Ishihara T, Takafuji A, Takayama T, Kanda Y, Sugizaki T, Tamura F, Kurotsu S, Kawahara M, Mizushima T.

Sci Rep. 2017 Jun 13;7(1):3439. doi: 10.1038/s41598-017-03676-y.

10.

Bile acid binding resin prevents fat accumulation through intestinal microbiota in high-fat diet-induced obesity in mice.

Kusumoto Y, Irie J, Iwabu K, Tagawa H, Itoh A, Kato M, Kobayashi N, Tanaka K, Kikuchi R, Fujita M, Nakajima Y, Morimoto K, Sugizaki T, Yamada S, Kawai T, Watanabe M, Oike Y, Itoh H.

Metabolism. 2017 Jun;71:1-6. doi: 10.1016/j.metabol.2017.02.011. Epub 2017 Feb 27.

PMID:
28521862
11.

Preventive Effects of Carnosine on Lipopolysaccharide-induced Lung Injury.

Tanaka KI, Sugizaki T, Kanda Y, Tamura F, Niino T, Kawahara M.

Sci Rep. 2017 Feb 16;7:42813. doi: 10.1038/srep42813.

12.

Upregulation of ANGPTL6 in mouse keratinocytes enhances susceptibility to psoriasis.

Tanigawa H, Miyata K, Tian Z, Aoi J, Kadomatsu T, Fukushima S, Ogata A, Takeda N, Zhao J, Zhu S, Terada K, Endo M, Morinaga J, Sugizaki T, Sato M, Morioka MS, Manabe I, Mashimo Y, Hata A, Taketomi Y, Yamamoto K, Murakami M, Araki K, Jinnin M, Ihn H, Oike Y.

Sci Rep. 2016 Oct 4;6:34690. doi: 10.1038/srep34690.

13.

ANGPTL2 activity in cardiac pathologies accelerates heart failure by perturbing cardiac function and energy metabolism.

Tian Z, Miyata K, Kadomatsu T, Horiguchi H, Fukushima H, Tohyama S, Ujihara Y, Okumura T, Yamaguchi S, Zhao J, Endo M, Morinaga J, Sato M, Sugizaki T, Zhu S, Terada K, Sakaguchi H, Komohara Y, Takeya M, Takeda N, Araki K, Manabe I, Fukuda K, Otsu K, Wada J, Murohara T, Mohri S, Yamashita JK, Sano M, Oike Y.

Nat Commun. 2016 Sep 28;7:13016. doi: 10.1038/ncomms13016.

14.

Evaluation of Lecithinized Superoxide Dismutase for the Prevention of Acute Respiratory Distress Syndrome in Animal Models.

Tanaka KI, Tamura F, Sugizaki T, Kawahara M, Kuba K, Imai Y, Mizushima T.

Am J Respir Cell Mol Biol. 2017 Feb;56(2):179-190. doi: 10.1165/rcmb.2016-0158OC.

PMID:
27668315
15.

Interstitial pneumonia induced by bleomycin treatment is exacerbated in Angptl2-deficient mice.

Motokawa I, Endo M, Terada K, Horiguchi H, Miyata K, Kadomatsu T, Morinaga J, Sugizaki T, Ito T, Araki K, Morioka MS, Manabe I, Samukawa T, Watanabe M, Inoue H, Oike Y.

Am J Physiol Lung Cell Mol Physiol. 2016 Oct 1;311(4):L704-L713. doi: 10.1152/ajplung.00005.2016. Epub 2016 Aug 19.

16.

Mice Deficient in Angiopoietin-like Protein 2 (Angptl2) Gene Show Increased Susceptibility to Bacterial Infection Due to Attenuated Macrophage Activity.

Yugami M, Odagiri H, Endo M, Tsutsuki H, Fujii S, Kadomatsu T, Masuda T, Miyata K, Terada K, Tanoue H, Ito H, Morinaga J, Horiguchi H, Sugizaki T, Akaike T, Gotoh T, Takai T, Sawa T, Mizuta H, Oike Y.

J Biol Chem. 2016 Sep 2;291(36):18843-52. doi: 10.1074/jbc.M116.720870. Epub 2016 Jul 11.

17.

Characterization of Tack Strength Based on Cavity-Growth Criterion.

Takahashi K, Yamagata Y, Inaba K, Kishimoto K, Tomioka S, Sugizaki T.

Langmuir. 2016 Apr 12;32(14):3525-31. doi: 10.1021/acs.langmuir.5b04705. Epub 2016 Mar 29.

PMID:
26991212
18.

Angiopoietin-like protein 2 increases renal fibrosis by accelerating transforming growth factor-β signaling in chronic kidney disease.

Morinaga J, Kadomatsu T, Miyata K, Endo M, Terada K, Tian Z, Sugizaki T, Tanigawa H, Zhao J, Zhu S, Sato M, Araki K, Iyama K, Tomita K, Mukoyama M, Tomita K, Kitamura K, Oike Y.

Kidney Int. 2016 Feb;89(2):327-41. doi: 10.1016/j.kint.2015.12.021. Epub 2016 Jan 1.

PMID:
26806834
19.

Intestinal Bile Acid Composition Modulates Prohormone Convertase 1/3 (PC1/3) Expression and Consequent GLP-1 Production in Male Mice.

Morimoto K, Watanabe M, Sugizaki T, Irie J, Itoh H.

Endocrinology. 2016 Mar;157(3):1071-81. doi: 10.1210/en.2015-1551. Epub 2016 Jan 20.

PMID:
26789236
20.

Bile acid binding resin improves hepatic insulin sensitivity by reducing cholesterol but not triglyceride levels in the liver.

Tagawa H, Irie J, Itoh A, Kusumoto Y, Kato M, Kobayashi N, Tanaka K, Morinaga R, Fujita M, Nakajima Y, Morimoto K, Sugizaki T, Kawano Y, Yamada S, Kawai T, Watanabe M, Itoh H.

Diabetes Res Clin Pract. 2015 Jul;109(1):85-94. doi: 10.1016/j.diabres.2015.04.025. Epub 2015 Apr 21.

PMID:
25981325
21.

The Niemann-Pick C1 like 1 (NPC1L1) inhibitor ezetimibe improves metabolic disease via decreased liver X receptor (LXR) activity in liver of obese male mice.

Sugizaki T, Watanabe M, Horai Y, Kaneko-Iwasaki N, Arita E, Miyazaki T, Morimoto K, Honda A, Irie J, Itoh H.

Endocrinology. 2014 Aug;155(8):2810-9. doi: 10.1210/en.2013-2143. Epub 2014 Apr 28.

PMID:
24773344
22.

Ameliorative effect of mepenzolate bromide against pulmonary fibrosis.

Kurotsu S, Tanaka K, Niino T, Asano T, Sugizaki T, Azuma A, Suzuki H, Mizushima T.

J Pharmacol Exp Ther. 2014 Jul;350(1):79-88. doi: 10.1124/jpet.114.213009. Epub 2014 Apr 25.

PMID:
24769542
23.

Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease.

Tanaka K, Ishihara T, Sugizaki T, Kobayashi D, Yamashita Y, Tahara K, Yamakawa N, Iijima K, Mogushi K, Tanaka H, Sato K, Suzuki H, Mizushima T.

Nat Commun. 2013;4:2686. doi: 10.1038/ncomms3686.

PMID:
24189798
24.

Bile acid binding resin improves metabolic control through the induction of energy expenditure.

Watanabe M, Morimoto K, Houten SM, Kaneko-Iwasaki N, Sugizaki T, Horai Y, Mataki C, Sato H, Murahashi K, Arita E, Schoonjans K, Suzuki T, Itoh H, Auwerx J.

PLoS One. 2012;7(8):e38286. doi: 10.1371/journal.pone.0038286. Epub 2012 Aug 29.

25.

Haworforbins A-C, new phenolics from Haworthia cymbiformis.

Yamasaki F, Machida S, Nakata A, Nugroho AE, Hirasawa Y, Kaneda T, Shirota O, Hagane N, Sugizaki T, Morita H.

J Nat Med. 2013 Jan;67(1):212-6. doi: 10.1007/s11418-012-0647-x. Epub 2012 Mar 16.

PMID:
22421814
26.

Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure.

Watanabe M, Horai Y, Houten SM, Morimoto K, Sugizaki T, Arita E, Mataki C, Sato H, Tanigawara Y, Schoonjans K, Itoh H, Auwerx J.

J Biol Chem. 2011 Jul 29;286(30):26913-20. doi: 10.1074/jbc.M111.248203. Epub 2011 Jun 1.

27.

Effects of alkylphenols on bone metabolism in vivo and in vitro.

Hagiwara H, Sugizaki T, Tsukamoto Y, Senoh E, Goto T, Ishihara Y.

Toxicol Lett. 2008 Sep;181(1):13-8. doi: 10.1016/j.toxlet.2008.06.863. Epub 2008 Jun 26.

PMID:
18621119
28.

Risk factors for the introduction of avian influenza virus into commercial layer chicken farms during the outbreaks caused by a low-pathogenic H5N2 virus in Japan in 2005.

Nishiguchi A, Kobayashi S, Yamamoto T, Ouchi Y, Sugizaki T, Tsutsui T.

Zoonoses Public Health. 2007;54(9-10):337-43.

PMID:
18035971
29.

Control of an outbreak of highly pathogenic avian influenza, caused by the virus sub-type H5N1, in Japan in 2004.

Nishiguchi A, Yamamoto T, Tsutsui Tl, Sugizaki T, Mase M, Tsukamoto K, Ito T, Terakado N.

Rev Sci Tech. 2005 Dec;24(3):933-44. Review.

30.

Copper(II) complexes of 1,10-phenanthroline-derived ligands: studies on DNA binding properties and nuclease activity.

Hirohama T, Kuranuki Y, Ebina E, Sugizaki T, Arii H, Chikira M, Tamil Selvi P, Palaniandavar M.

J Inorg Biochem. 2005 May;99(5):1205-19.

PMID:
15833344
31.

Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-beta in human umbilical vein endothelial cells.

Ota T, Fujii M, Sugizaki T, Ishii M, Miyazawa K, Aburatani H, Miyazono K.

J Cell Physiol. 2002 Dec;193(3):299-318.

PMID:
12384983
32.

DNA-fiber EPR study of the orientation of Cu(II) complexes of 1,10-phenanthroline and its derivatives bound to DNA: mono(phenanthroline)-copper(II) and its ternary complexes with amino acids.

Chikira M, Tomizawa Y, Fukita D, Sugizaki T, Sugawara N, Yamazaki T, Sasano A, Shindo H, Palaniandavar M, Antholine WE.

J Inorg Biochem. 2002 Apr 28;89(3-4):163-73.

PMID:
12062119
33.

[Clinicopathological significance of immune complex (IC) along the tubular basement membrane (TBM) in lupus nephritis].

Shinbo H, Kobayashi K, Boku S, Akagi T, Totsuka D, Saito K, Kitazawa K, Ito S, Sugizaki T.

Arerugi. 1993 Aug;42(8):941-7. Japanese.

PMID:
8250734
34.

[Clinical symptoms and therapy of lupus nephritis].

Sugizaki T.

Nihon Naika Gakkai Zasshi. 1990 Oct 10;79(10):1387-92. Japanese. No abstract available.

PMID:
2269813
35.

[Effects of combination therapy of carmofur and nicardipine of human gastric cancer in nude mice].

Nakatani K, Ezaki T, Sakamoto K, Sugizaki T, Miyagi N.

Gan To Kagaku Ryoho. 1985 Apr;12(4):969-71. Japanese. No abstract available.

PMID:
3985648
36.

Supplemental Content

Loading ...
Support Center